EUVIMEDEUVIMED entdecken
Crossref

Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period

Haruka Ide, Yukako Kawasaki, Kentaro Tamura, Taketoshi Yoshida, Ryosuke Fujihara, Akane Hara, Masato Taguchi

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b23-00650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Haruka Ide und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Sciences, School of Pharmacy and Pharmaceutical Sciences, University of Toyama. Hauptthemen laut MEDLINE: Caffeine, Gestational Age, Infant, Premature, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taguchi et al. reported that postmenstrual age (PMA) is a promising factor in describing and understanding the developmental change of caffeine (CAF) clearance. The aim of the present study was to quantify how developmental changes occur and to determine the effect of the length of the gestational period on CAF clearance. We performed a nonlinear mixed effect model (NONMEM) analysis and evaluated the fit of six models. A total of 115 samples were obtained from 52 patients with a mean age of 34.3 ± 18.2 d. The median values of gestational age (GA) and postnatal age (PNA) were 196 and 31 d, respectively. Serum CAF levels corrected for dose per body surface area (BSA) (C/D ratioBSA) were dependent on PMA rather than PNA, which supports the findings of a previous study. NONMEM analysis provided the following final model of oral clearance: CL/F = 0.00603∙WT∙ ∙0.877GA ≤ 196 L/h. This model takes into account developmental changes during prenatal and postnatal periods separately. The model successfully described the variation in clearance of CAF. Our findings suggest that the dosage of CAF in preterm infants should be determined based not only on body weight (WT) but also on both PNA and GA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineGestational AgeInfant, PrematureModels, BiologicalHumansFemaleInfant, NewbornMalePregnancyCentral Nervous System Stimulants

Stichwörter der Autor:innen

caffeinegestational agenonlinear mixed effect modelpostmenstrual agepostnatal agepreterm infant

Substanzen

CaffeineCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Sciences, School of Pharmacy and Pharmaceutical Sciences, University of Toyama.
  • Division of Neonatology, Maternal and Perinatal Center, Toyama University Hospital.
  • Laboratory of Pharmaceutical Quality Assurance and Assessment, School of Pharmacy and Pharmaceutical Sciences, University of Toyama.

Zitieren

APA

Ide, H., Kawasaki, Y., Tamura, K., Yoshida, T., Fujihara, R., Hara, A., & Taguchi, M. (2024). Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00650

Vancouver

Ide H, Kawasaki Y, Tamura K, Yoshida T, Fujihara R, Hara A, et al. Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00650

BibTeX
@article{Ide2024,
  author = {Ide, Haruka and Kawasaki, Yukako and Tamura, Kentaro and Yoshida, Taketoshi and Fujihara, Ryosuke and Hara, Akane and Taguchi, Masato},
  title = {Modeling Developmental Changes in Caffeine Clearance Considering Differences between Pre- and Postnatal Period},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b23-00650}
}
Kostenlos starten →